Short answer
Humana (HUM) filed an 8-K current report with the SEC on July 29, 2026 reporting Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1). Q2 2026 financial results released for quarter ended June 30, 2026.
Humana 8-K event analysis
AI summary of each reported item and its exhibits
Item 7.01 · Regulation FD Disclosure
- Q2 2026 financial results released for quarter ended June 30, 2026
- Detailed earnings release and management remarks available in Exhibits 99.1–99.3
- Management commentary includes expectations for future earnings, relevant to outlook assessment
Item EX-99.1 · Exhibit EX-99.1
- 2Q26 GAAP EPS $5.73 and adjusted EPS $7.61, up from $4.51 and $6.27 respectively
- Insurance benefit ratio 91.2%, supporting affirmed FY2026 guidance of 92.75% ±25 basis points
- Adjusted EPS guidance affirmed at least $9.00, while GAAP guidance cut to at least $6.52 from $8.36
- Individual Medicare Advantage membership growth target maintained at approximately 25% over 2025
- CenterWell Senior Primary Care patients increased 130,900, or 27%, year to date; Illinois Medicaid contract begins January 2027
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Humana 8-K filings
Get the next HUM 8-K as it lands
Follow HUM for push alerts, or ask the research agent what this filing means.